RIPK1 and cancer: Cytosolic innate immune regulators and sensors, such as ZBP1, RIPK1, and AIM2promote the assembly of PANoptosomes to drive PANoptosis 2, and studies highlight recent progress in cancer treatment based on PANoptosis and ferroptosis induced by other small-molecule compounds, immune checkpoint inhibitors, and nanoparticles 104.